PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 46 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

8 March 2025

  1. (diff | hist) 01:13 Glucagon-like peptide-1 10,239 +47 ScopeSeverin (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  2. (diff | hist) 01:05 Hypoglycaemia 3,743 ±0 SarcopeniaSefa (talk | contribs) clarify that the rodent finding has not been observed in humans [rollback]
  3. (diff | hist) m b 00:02 Injection site rotation 3,897 ±0 CiteBot (talk | contribs) bot: add stub category [rollback]

7 March 2025

  1. (diff | hist) m 20:07 Methionine oxidation 3,582 +106 Chromatokid (talk | contribs) add short description [rollback]
  2. (diff | hist) 18:24 Underfilling 2,520 ±0 EndotoxinEd (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  3. (diff | hist) m b 17:55 Trial data comparison 3,174 +339 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) m 15:15 Peptide supply chain 6,060 +744 PrepHPLC_Pia (talk | contribs) sentence case in headings per PP:MOS [rollback]
  5. (diff | hist) m b 12:34 Certificate of analysis 6,972 +576 ArchiveBot (talk | contribs) bot: add maintenance category [rollback]
  6. (diff | hist) 11:52 Talk:ChinaPeptides 1,170 +138 CDMO_Caradoc (talk | contribs) /* Custom synthesis needs its own risk paragraph */ reply
  7. (diff | hist) m 01:24 Counterfeit peptide 3,343 +610 ShortDescShai (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]

6 March 2025

  1. (diff | hist) 20:21 Triple agonist 3,428 +186 CouplingCillian (talk | contribs) unpipe a link that did not need piping [rollback]
  2. (diff | hist) 20:04 Electrospray ionisation 3,478 +252 FormularyFrida (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  3. (diff | hist) m 17:04 Reconstitution of lyophilised peptides 4,389 ±0 DeadSpaceDot (talk | contribs) clarify which volume the graduation marks measure [rollback]
  4. (diff | hist) 15:21 Adverse effects of GLP-1 receptor agonists 4,695 ±0 CostPerMgCory (talk | contribs) clarify that the effect resolved on discontinuation in the cited series [rollback]
  5. (diff | hist) m 15:19 Haemoglobin A1c 3,366 ±0 AnaesthesiaAoife (talk | contribs) rm the diagnostic threshold — the article describes, it does not diagnose [rollback]
  6. (diff | hist) m 15:12 USP General Chapter 85 3,581 +130 LOD_Lorcan (talk | contribs) add the reference standard and its traceability [rollback]
  7. (diff | hist) m b 13:38 Exenatide 4,288 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  8. (diff | hist) 13:08 Lot traceability 4,002 ±0 PancreasPru (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  9. (diff | hist) 09:05 Talk:ChinaPeptides 959 +177 PrepHPLC_Pia (talk | contribs) /* Custom synthesis needs its own risk paragraph */ reply
  10. (diff | hist) m 07:41 GLP-1 receptor agonist 9,254 ±0 ParentCatPansy (talk | contribs) ce per PP:MOS [rollback]
  11. (diff | hist) 00:44 High-performance liquid chromatography 5,364 ±0 ResolutionRoo (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]

5 March 2025

  1. (diff | hist) 21:58 LEADER trial 3,537 ±0 TrialsTabitha (talk | contribs) rm the survival claim — no mortality endpoint was pre-specified [rollback]
  2. (diff | hist) 19:03 Deamidation 4,197 +666 ColumnOvenCoy (talk | contribs) add the equilibration time to the gradient description [rollback]
  3. (diff | hist) 15:00 Test report forgery 4,015 +24 EndotoxinEd (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  4. (diff | hist) 14:29 Talk:ChinaPeptides 748 +164 MassSpecMarv (talk | contribs) /* Custom synthesis needs its own risk paragraph */ reply
  5. (diff | hist) 12:43 Amino acid analysis 3,582 +961 CuriousCallum (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  6. (diff | hist) 10:55 Flourishglobal Peptide Biotech 2,803 +672 PrimarySrcPatia (talk | contribs) add the standing talk-page note link to the banner [rollback]
  7. (diff | hist) m 10:32 Orforglipron 4,056 +719 MassSpecMarv (talk | contribs) fix the anchor on an internal link [rollback]
  8. (diff | hist) 10:11 Talk:ChinaPeptides 537 +249 CDMO_Caradoc (talk | contribs) /* Custom synthesis needs its own risk paragraph */ new section
  9. (diff | hist) 09:07 Number needed to treat 3,631 ±0 PreregPriya (talk | contribs) rm a duplicated category [rollback]

4 March 2025

  1. (diff | hist) 18:49 Liraglutide 4,532 +237 IcodecIndra (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) m b 15:52 Semaglutide 8,079 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 13:42 Fmoc chemistry 3,718 ±0 MissedDoseMik (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  4. (diff | hist) 10:09 Insulin syringe unit conversion 3,664 +124 CuriousCallum (talk | contribs) add the reset control description [rollback]

3 March 2025

  1. (diff | hist) m 19:44 Cold-chain freight 3,225 +114 ResinRhoswen (talk | contribs) expand §Monitoring [rollback]
  2. (diff | hist) 17:48 HOMA-IR 3,431 +120 DEXA_Dilys (talk | contribs) state the assay the reference interval was established on [rollback]
  3. (diff | hist) m 17:15 Peptide 4,933 ±0 ChromCleanupCass (talk | contribs) unpipe a link that did not need piping [rollback]
  4. (diff | hist) m 16:27 Lixisenatide 3,215 +180 RetatrutideRuben (talk | contribs) convert a hard-coded date to the house format [rollback]
  5. (diff | hist) m 14:02 VendorInvestigate 4,188 ±0 SecondarySrc_Seb (talk | contribs) unpipe a link that did not need piping [rollback]
  6. (diff | hist) 08:51 Sterility testing 3,235 ±0 ChromCleanupCass (talk | contribs) add the detection wavelength [rollback]
  7. (diff | hist) m 07:27 ISO 9001 3,340 +211 CarryOverCai (talk | contribs) close an unbalanced quotation mark [rollback]
  8. (diff | hist) m 03:12 C-peptide 3,250 ±0 PlainNumbersPip (talk | contribs) state the fasting requirement explicitly [rollback]

2 March 2025

  1. (diff | hist) 19:33 Bachem Holding (Suzhou) 8,893 +798 ReportReaderRilla (talk | contribs) expand §Corporate identity and history [rollback]
  2. (diff | hist) m 19:09 SUSTAIN trial programme 4,187 +18 ForestPlotFinn (talk | contribs) split the results table so the two doses are separate rows [rollback]
  3. (diff | hist) m 15:25 Customs seizure 3,014 +28 AAA_Analyst (talk | contribs) expand §What it does and does not indicate [rollback]
  4. (diff | hist) 11:21 Proglucagon 5,725 +727 IpamorelinIsold (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  5. (diff | hist) 08:46 Cold chain 18,800 +317 CounterfeitCato (talk | contribs) British spelling per PP:MOS [rollback]
  6. (diff | hist) m b 05:39 Dipeptidyl peptidase-4 5,763 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  7. (diff | hist) 03:32 Shanghai Sigma-Audley New Material Technology 7,010 +347 SortKeySascha (talk | contribs) split overlong sentence [rollback]

1 March 2025

  1. (diff | hist) 20:45 FLOW trial 3,169 ±0 MassSpecMarv (talk | contribs) expand §Results [rollback]
  2. (diff | hist) 19:48 Sangon Biotech 5,939 +643 BlindSampleBrid (talk | contribs) expand §Independent testing record [rollback]
  3. (diff | hist) 15:11 Peptide harm reduction 2,785 ±0 BlankVialBo (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) 14:04 Blind sampling 6,780 +1,130 SupplyWatchSuri (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  5. (diff | hist) m 13:23 ChinaPeptides 7,007 +144 IncretinIvo (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  6. (diff | hist) m 07:54 Retatrutide 5,700 ±0 Chromatokid (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  7. (diff | hist) 07:08 Active pharmaceutical ingredient 2,868 +36 PharmDrafts (talk | contribs) expand §The regulatory frame [rollback]
  8. (diff | hist) m b 04:58 Dose escalation schedule 3,632 +122 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  9. (diff | hist) 03:11 PeptideMeter 3,734 ±0 SurvodutideSaff (talk | contribs) state that the report identifies the sample, not the shipment [rollback]
  10. (diff | hist) 00:32 Subcutaneous injection 4,039 ±0 UnitsUrsula (talk | contribs) ce [rollback]

28 February 2025

  1. (diff | hist) m 23:23 Crude peptide 3,651 ±0 CrudePeptidePearl (talk | contribs) copyedit [rollback]
  2. (diff | hist) 11:07 Glucose-dependent insulinotropic polypeptide 6,686 ±0 TrialsTabitha (talk | contribs) copyedit [rollback]
  3. (diff | hist) 08:57 Shanghai Wibson Biotechnology 5,310 +979 VerifyVesna (talk | contribs) serial comma per PP:MOS [rollback]
  4. (diff | hist) 05:43 Tirzepatide 6,329 +95 OralSemaOswin (talk | contribs) give the INN alongside the trade name at first mention [rollback]
  5. (diff | hist) 03:44 Glossary of peptide terminology 3,581 ±0 ColdChainCleo (talk | contribs) de-orphan [rollback]
  6. (diff | hist) 03:30 MOTS-c 2,663 ±0 TB500_Tarquin (talk | contribs) add a hatnote separating this from the fragment of the same parent protein [rollback]
  7. (diff | hist) m 02:05 Guangzhou JEEP Biotechnology 9,654 +839 BatchNumberBede (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]

27 February 2025

  1. (diff | hist) m 15:25 Regulatory status by jurisdiction 3,277 +556 DMF_Dermot (talk | contribs) add the note that this wiki does not give legal advice [rollback]
  2. (diff | hist) 11:56 Lyophilisation 17,642 ±0 ToleranceTove (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]
  3. (diff | hist) m 06:17 Chinese Peptide Company 9,495 +256 EndotoxinEd (talk | contribs) ce per PP:MOS [rollback]

26 February 2025

  1. (diff | hist) m 22:40 Growth hormone secretagogue 3,433 +83 KPV_Kester (talk | contribs) rm the aggregate purity claim — no source, and no such survey exists [rollback]
  2. (diff | hist) 22:24 Reference standard 4,120 ±0 TFA_Counterion (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  3. (diff | hist) m b 19:38 Purity claim inflation 3,603 ±0 ArchiveBot (talk | contribs) bot: add maintenance category [rollback]
  4. (diff | hist) 17:11 Incretin effect 5,425 ±0 SchematicScout (talk | contribs) clarify that concentrations differ substantially between assay platforms [rollback]
  5. (diff | hist) 13:25 Melanotan II 3,358 ±0 DisclosureDido (talk | contribs) rm "clinically proven" — nothing cited supports the phrase [rollback]
  6. (diff | hist) m 12:40 Beta cell function 4,916 +588 LeanMassLars (talk | contribs) rm a duplicated category [rollback]
  7. (diff | hist) 12:07 Janoshik Analytical 4,126 ±0 Peptide_Pete (talk | contribs) rm the inference from one report to a supplier [rollback]
  8. (diff | hist) m b 11:28 Missed dose 4,123 ±0 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  9. (diff | hist) N 09:00 Flourishglobal Peptide Biotech 2,131 +2,131 TierTwoTansy (talk | contribs) start organisation article — registry facts and product scope only
  10. (diff | hist) 08:18 Hunan Aslsen Technology 7,715 ±0 TrialsTabitha (talk | contribs) expand §Ordering and availability [rollback]
  11. (diff | hist) m b 07:19 Multi-dose vial 4,366 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  12. (diff | hist) 04:23 Glucagon 5,754 +841 TirzTaxonomist (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]

25 February 2025

  1. (diff | hist) 18:00 Grey market 2,576 ±0 Chromatokid (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  2. (diff | hist) m b 17:46 Survodutide 4,005 +32 ArchiveBot (talk | contribs) bot: add drug-class category [rollback]
  3. (diff | hist) m 16:46 Good manufacturing practice 3,548 ±0 GreyMarketGreer (talk | contribs) add the pharmacopoeial chapter reference [rollback]
  4. (diff | hist) 13:09 CagriSema 3,887 +111 ComparisonCato (talk | contribs) de-duplicate a repeated sentence [rollback]
  5. (diff | hist) 12:54 Beyond-use date 11,093 +618 SharpsSukhi (talk | contribs) add a second worked example at a different vial strength [rollback]
  6. (diff | hist) m b 08:03 Chain of custody 3,916 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  7. (diff | hist) m 04:09 Repackaging 3,958 +21 CustomsClarke (talk | contribs) expand §Repackaging as a market structure [rollback]
  8. (diff | hist) 03:54 Reverse-phase HPLC 4,246 ±0 BlindSampleBrid (talk | contribs) expand §Reading a reported determination [rollback]
  9. (diff | hist) m 03:34 Patent expiry and biosimilars 3,173 +595 BUD_Bertram (talk | contribs) add the date the shortage listing ended [rollback]
  10. (diff | hist) 02:38 Contract development and manufacturing organisation 3,462 +587 AnalyticalAnnie (talk | contribs) clarify that the cake appearance is an indicator, not a specification [rollback]
  11. (diff | hist) 00:27 Tianjin Finder Chemical 6,463 +301 eGFR_Esme (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]

24 February 2025

  1. (diff | hist) m b 16:13 Liquid chromatography-mass spectrometry 3,451 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) m 15:49 Prescribing information 3,458 ±0 DEXA_Dilys (talk | contribs) expand §Structure [rollback]
  3. (diff | hist) m 15:09 Fasting insulin 2,962 ±0 B12_Bettina (talk | contribs) expand §Behaviour under treatment [rollback]
  4. (diff | hist) 14:22 Amylin 4,252 +296 TrialsTabitha (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  5. (diff | hist) 04:25 Sarcopenia 2,738 ±0 B12_Bettina (talk | contribs) split the analytical performance from the clinical interpretation [rollback]
  6. (diff | hist) 03:12 Trial data comparison 2,835 +439 MergeMorwenna (talk | contribs) correct the column header — that column is volume [rollback]
  7. (diff | hist) 03:05 Loss on drying 3,735 +397 KarlFischerKit (talk | contribs) expand §Why the distinction from water matters [rollback]
  8. (diff | hist) m 01:16 Insulin syringe 4,111 ±0 DeadSpaceDot (talk | contribs) add a second worked example at a different vial strength [rollback]